107.521 articles found

Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders.

Rouse ST, Marino MJ, Bradley SR, Awad H, Wittmann M, Conn PJ.

Pharmacol Ther · 2000-12-01

DOI: 10.1016/s0163-7258(00)00098-xPMID: 11337032

Ante litteram description of atypical parkinsonian cases.

Brusa A, Pramstaller PP.

Neurol Sci · 2000-12-01

DOI: 10.1007/s100720070057PMID: 11441579

[Autosomal recessive juvenile parkinsonism: its pathogenesis is involved in the ubiquitin-proteasome pathway].

Hattori N, Shimura H, Kubo S, Suzuki T, Tanaka K, Mizuno Y.

Rinsho Shinkeigaku · 2000-12-01

PMID: 11464483

Asymmetry of sympathetic activity in a rat model of Parkinson's disease induced by 6-hydroxydopamine: haemodynamic, electrocardiographic and biochemical changes.

Jellestad FK, Mathisen JR, Thorsen T, Wester K, Aakvaag A.

Res Exp Med (Berl) · 2000-12-01

PMID: 11678149

Entacapone: adjunctive use in patients with advanced Parkinson's disease.

McAuley L.

Issues Emerg Health Technol · 2000-12-01

PMID: 11902220

[Effects of yanggan xifeng recipe on changes of neurological behavior of rat of Parkinson's model].

Li W, Cai D, Chen X.

Zhongguo Zhong Xi Yi Jie He Za Zhi · 2000-12-01

PMID: 11938865

Parkinson's disease: the challenge.

Noble C.

Nurs Stand · 2000-12-01

DOI: 10.7748/ns2000.12.15.12.43.c2954PMID: 11971589

Transdermal therapeutic system which contains a d2 agonist and which is provided for treating parkinsonism, and a method for the production thereof

MULLER WALTER, PECK JAMES V.

· 2000-11-28

Apparatus for the transdermal treatment of Parkinson's disease

KUSHNIR MOSHE, HELDMAN ELIAHU.

· 2000-11-13

In vivo PET studies of the dopamine D2 receptors in rhesus monkeys with long-term MPTP-induced parkinsonism.

Doudet DJ, Holden JE, Jivan S, McGeer E, Wyatt RJ.

Synapse · 2000-11-01

DOI: 10.1002/1098-2396(200011)38:2<105::aid-syn1>3.0.co;2-sPMID: 11018784

Voiding dysfunction and Parkinson's disease: urodynamic abnormalities and urinary symptoms.

Araki I, Kitahara M, Oida T, Kuno S.

J Urol · 2000-11-01

DOI: 10.1016/s0022-5347(05)67048-6PMID: 11025724

Treatment of Parkinson's disease.

Hely MA, Fung VS, Morris JG.

J Clin Neurosci · 2000-11-01

DOI: 10.1054/jocn.2000.0766PMID: 11029227